Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes

Stephen J. Nicholls

Victorian Heart Institute, Monash University, Melbourne, VIC, Australia

Imre Pavo

Eli Lilly, Indianapolis

Deepak L. Bhatt

Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York

John B. Buse

Stefano Del Prato

Interdisciplinary Research Center “Health Science,” Sant’Anna School of Advanced Studies, Pisa, Italy

Steven E. Kahn

A. Michael Lincoff

Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland

Darren K. McGuire

University of Texas Southwestern Medical Center, Dallas

Debra Miller

Michael A. Nauck

Diabetes, Endocrinology, and Metabolism Section, Department of Medicine, St. Josef-Hospital, Katholisches Klinikum Bochum, Ruhr University of Bochum, Bochum, Germany

Hiroshi Nishiyama

Eli Lilly, Indianapolis

Steven E. Nissen

Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland

Naveed Sattar

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom

Govinda Weerakkody

Eli Lilly, Indianapolis

Russell J. Wiese

Eli Lilly, Indianapolis

Bernard Zinman

Lunenfeld–Tanenbaum Research Institute, University of Toronto, Toronto

Sophia Zoungas

Victorian Heart Institute, Monash University, Melbourne, VIC, Australia

Jan Basile

Medical University of South Carolina, Charleston

Melanie J. Davies

Francesco Giorgino

Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Italy

Monika Kellerer

Department of Medicine 1, Marienhospital Stuttgart, Stuttgart, Germany

Linong Ji

Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing

Tamas Varkonyi

Department of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary

Venu Menon

Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland

Jonathan C. Broder

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia

Alan Herschtal

Monash University Clinical Trials Centre, Monash University, Melbourne, VIC, Australia

David D’Alessio

Duke University Medical Center, Durham, NC